{"disease":{"id":"intracranial-meningioma","name":"intracranial meningioma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07376473","title":"Psychometric Validation of the MQOL-FR and Descriptive Assessment of Quality of Life in Patients With Meningiomas","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":238,"lead_sponsor_name":"Centre Hospitalier St Anne","has_results":false},{"nct_id":"NCT03180268","title":"Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":163,"lead_sponsor_name":"NRG Oncology","has_results":false},{"nct_id":"NCT05832099","title":"Cognition-preserving Brain Irradiation for Treating Patients With Intracranial Meningioma in the Era of Modern Radiotherapeutic Techniques Including Proton Beam Therapy - a Prospective Study Focusing on Radiological Outcomes and Neurocognitive Endpoints","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":74,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}